EBMT 2019 | Challenges after CAR T-cell therapy

David Maloney

Here, David Maloney, MD, PhD, of Fred Hutchinson Cancer Research Center, Seattle, WA, explains the challenges that are faced in the management of patients that undergo CAR T-cell therapy. Dr Maloney was speaking at the European Society for Blood and Marrow Transplantation (EBMT) 2019 Annual Meeting, held in Frankfurt, Germany.

Share this video  
Similar topics